In Vitro MASLD and MASH Models: Selecting Primary Human Liver Cells for Metabolic Disease Research

In Vitro MASLD and MASH Models: Selecting Primary Human Liver Cells for Metabolic Disease Research

Primary human hepatocytes and NPCs outperform cell lines in MASLD and MASH in vitro models. Compare cell sources for more predictive metabolic liver disease assays. Read full blog at BioIVT.

Related Posts

Translating NAMs into Practical Drug Discovery Workflows Using Human-Derived Models
Translating NAMs into Practical Drug Discovery Workflows Using Human-Derived Models
Gallery

Translating NAMs into Practical Drug Discovery Workflows Using Human-Derived Models

11/05/2026
Primary Human Lung Cells in Disease Modeling and Drug Development
https://bioivt.com/blogs/primary-human-lung-cells-in-disease-modeling-and-drug-development
Gallery

Primary Human Lung Cells in Disease Modeling and Drug Development

07/04/2026
Regulatory Access to Biospecimens in the European Union: Procurement, Collection & Compliance for Research
https://bioivt.com/blogs/regulatory-access-to-biospecimens-in-the-european-union-procurement-collection-compliance-for-research
Gallery

Regulatory Access to Biospecimens in the European Union: Procurement, Collection & Compliance for Research

18/03/2026
New Approach Methodologies (NAMs) in Preclinical Research: Redefining Toxicology Without Animal Models
https://bioivt.com/blogs/new-approach-methodologies-nams-in-preclinical-research-redefining-toxicology-without-animal-models
Gallery

New Approach Methodologies (NAMs) in Preclinical Research: Redefining Toxicology Without Animal Models

02/03/2026